Zomedica Pharmaceuticals Corp. (ZOM) has seen some recent activity in the market and its common shares were last quoted at $0.2310 yesterday. People are starting to take notice of ZOM as the common shares traded as high as $0.2345 and as low as $0.2201 in the previous market session.
Zomedica Pharmaceuticals Corp. (ZOM) average trading volume is 24.62M. However, in the previous market session Zomedica Pharmaceuticals Corp. (ZOM) traded 14,285,256 shares. The first support level on ZOM is $0.21 and the first resistance level on ZOM is $0.42. ZOM 50day moving average is $0.1822 and ZOM 200day moving average is $0.2536.
Zomedica Pharmaceuticals Corp. (ZOM) most recent performance has been shown by the recent movement in ZOM common shares. ZOM has performed 60.53% over the past month, ZOM has performed 86.74% over the past 3 months and ZOM has shown -20.34% over the past year. Zomedica Pharmaceuticals Corp. (ZOM) has a 1 year range of $0.1100 to $0.4990. Zomedica Pharmaceuticals Corp. (ZOM) is trading 110.00% from its 1 year low and -53.71% from its 1 year high. Zomedica Pharmaceuticals Corp. (ZOM) is displaying a 7.80% short float displaying the quantity short in the float.
ZOM has 118.34M shares outstanding and 104.17M shares in the float. Zomedica Pharmaceuticals Corp. (ZOM) at this time has a market cap of $39.90M and income of $-19.80M. The projected EPS net year is 57.10%. The market cap of Zomedica Pharmaceuticals Corp. (ZOM) at $39.90M signifies how many People own shares of ZOM and is based off the last price ($0.2310) of ZOM and the quantity of shares outstanding (118.34M) with Zomedica Pharmaceuticals Corp. (ZOM).
Zomedica Pharmaceuticals Corp. (ZOM) has aggregate cash (mrq) of 1.54M, aggregate cash per share (mrq) of 0.01. Zomedica Pharmaceuticals Corp. (ZOM) operating cash flow (ttm) is -15.63M and ZOM leveraged free cash flow (ttm) is -8.83M.
ZOM is trading 18.05% above (bullish) its SMA20, 26.63% above (bullish) its SMA50 and -17.50% below (bearish) its SMA200.
Recent News:
In recent news, on May 11, 2020, Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, reported consolidated financial results for the first quarter ended March 31, 2020. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”).
